Development of a Doxorubicin−Sitosterol Conjugate as a Radiosensitizer for Cancer Therapy
ACS Applied Bio Materials · 2026
DOI: 10.1021/acsabm.6c00038 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Jae-Won Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea. Hauptthemen laut MEDLINE: Doxorubicin, Radiation-Sensitizing Agents, Sitosterols, Biocompatible Materials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Engineering Research Centers.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.
- Department of Chemistry, College of Natural Sciences, The University of Texas at Austin, Austin, Texas 78712, United States.
- Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.
ORCID-Profile: Sungjin Jeon, Jong-Soo Choi
Förderung
- Engineering Research Centers
Zitieren
APA
Park, J. W., Doh, K. O., Jeon, S., Kim, K. S., Heo, J. I., & Choi, J. S. (2026). Development of a Doxorubicin−Sitosterol Conjugate as a Radiosensitizer for Cancer Therapy. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00038
Vancouver
Park JW, Doh KO, Jeon S, Kim KS, Heo JI, Choi JS. Development of a Doxorubicin−Sitosterol Conjugate as a Radiosensitizer for Cancer Therapy. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00038
BibTeX
@article{Park2026,
author = {Park, Jae-Won and Doh, Kyung-Oh and Jeon, Sungjin and Kim, Kwang Seok and Heo, Jong-Ik and Choi, Jong-Soo},
title = {Development of a Doxorubicin−Sitosterol Conjugate as a Radiosensitizer for Cancer Therapy},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c00038}
}
EUVIMED